← back to search

Huaiying Lin

University of Chicago · US
Area of research
Molecular Biology · Infectious Diseases
Research interest
Research interests include Gut microbiota and health, Clostridium difficile and Clostridium perfringens research, Probiotics and Fermented Foods, and Helicobacter pylori-related gastroenterology studies.
h-index
9
citations
331
works
27
NIH funding
primary concept
email

Recent publications

Fecal Microbial Profiles and Short-Chain Fatty Acid/Bile Acid Metabolomics in Patients With Age-Related Macular Degeneration: A Pilot Study
Investigative Ophthalmology & Visual Science 2025cited by 10position: middledoi
Gut bacteria metabolize natural and synthetic steroid hormones via the reductive OsrABC pathway
Cell Host & Microbe 2025cited by 9position: middledoi
Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease
Gastro Hep Advances 2025cited by 5position: middledoi
Comprehensive analyses of a large human gut Bacteroidales culture collection reveal species- and strain-level diversity and evolution
Cell Host & Microbe 2024cited by 35position: middledoi
Activity of Gut-Derived Nisin-like Lantibiotics against Human Gut Pathogens and Commensals
ACS Chemical Biology 2024cited by 23position: middledoi
Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease
Nature Microbiology 2023cited by 62position: middledoi
Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection
Cell Host & Microbe 2023cited by 31position: middledoi
Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027) Clostridioides difficile
Cell Reports 2023cited by 24position: middledoi
Oral Metformin Inhibits Choroidal Neovascularization by Modulating the Gut-Retina Axis
Investigative Ophthalmology & Visual Science 2023cited by 21position: middledoi
Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure
Nature Communications 2022cited by 71position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Anitha Sundararajan · University of Chicago7 papers (2023–2025)Ashley M. Sidebottom · University of Chicago6 papers (2023–2025)Nicholas P. Dylla · Ecolab (United Kingdom)5 papers (2023–2025)Ramanujam Ramaswamy · University of Chicago5 papers (2023–2025)Eric G. Pamer · Mahindra and Mahindra Limited (India)5 papers (2023–2025)Victoria Burgo · Bellevue College3 papers (2023–2025)Che Woodson · University of Chicago3 papers (2023–2025)Dinanath Sulakhe · University of Chicago3 papers (2023–2025)Mark D’Souza · University of Chicago3 papers (2023–2025)Mary McMillin · University of Chicago3 papers (2024–2025)Jessica Little · Duchossois Group (United States)3 papers (2023–2025)Jason Xiao · University of Chicago2 papers (2023–2025)Christopher Lehmann · University of Chicago2 papers (2023–2025)Andrew Aronsohn · Cleveland Clinic Lerner College of Medicine2 papers (2023–2025)Rita C. Smith · Northern Illinois University2 papers (2023–2024)Jackelyn Cantoral · Bellevue College2 papers (2023–2025)Angelica Moran · University of Chicago2 papers (2023–2025)Téa E. Pappas · University of Chicago2 papers (2024–2024)Dimitra Skondra · University of Chicago2 papers (2023–2025)Hugo Barba · University of Chicago2 papers (2023–2025)